Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025)
Siga Technologies (SIGA) reported Change in Accured Expenses of $6.3 million for Q3 2025, up 728.17% on a YoY basis from $766720.0 in Q3 2024, and up 165.89% quarter-over-quarter from -$9.6 million in Q2 2025.
Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Siga Technologies has reported Change in Accured Expenses for 16 years, with the latest figure at $6.3 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Accured Expenses rose 728.17% year-over-year to $6.3 million; the trailing twelve-month figure through Sep 2025 stood at $5.0 million (up 346.95% YoY), and the FY2024 full-year result was -$5.7 million, down 387.43% from the prior year.
- Change in Accured Expenses for Q3 2025 stood at $6.3 million, up from -$9.6 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $11.0 million in Q3 2021, with the low at -$9.6 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $336053.5 across 5 years, with a median of $619665.0 in 2022.
- The largest YoY upside for Change in Accured Expenses was 728.17% in 2025 against a maximum downside of 906.11% in 2025.
- Siga Technologies' Change in Accured Expenses stood at -$7.6 million in 2021, then jumped by 108.13% to $619665.0 in 2022, then jumped by 161.02% to $1.6 million in 2023, then tumbled by 228.58% to -$2.1 million in 2024, then soared by 405.32% to $6.3 million in 2025.
- The last three Change in Accured Expenses figures came in at $6.3 million (Q3 2025), -$9.6 million (Q2 2025), and $10.4 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.35 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 766,720.00 |
| Sep 30, 2024 | 766,720.00 |
| Jun 30, 2024 | -957,798.00 |
| Jun 30, 2024 | -957,798.00 |
| Mar 31, 2024 | -3.47 Mn |
| Mar 31, 2024 | -3.47 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.93 Mn |